Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller

PsychRounds: The Psychiatry Podcast

Health EN ↓ 122 episodes

Welcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge. Contact us: psychroundspodcast@gmail.comInstagram: https://www.instagram.com/psychrounds/

Be sure to visit the podcast's website and support the creator: podcasters.spotify.com

Author

Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller

Category

Health

Podcast website

podcasters.spotify.com

Latest episode

Nov 18, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Landmark Studies: STEP-BD 18.11.2026

Welcome back! Our journal club continues... today we are going over the Systematic Treatment Enhancement Program for Bipolar Disorder, more commonly known as "STEP-BD". References:   https://www.nejm.org/doi/full/10.1056/NEJMoa064135 https://pubmed.ncbi.nlm.nih.gov/12788248 https://onlinelibrary.wiley.com/doi/10.1111/j.1399-5618.2009.00715.x https://pubmed.ncbi.nlm.nih.gov/16449474/ http...

A Validity-Based Diagnostic Hierarchy with Dr. Mark Ruffalo and Dr. Ronald Pies 04.11.2026

Today, we welcome back a former guest, Dr. Mark Ruffalo, and joining him is his colleague and co-author, Dr. Ronald Pies. We will be discussing their recently published article, The Need For A Validity-Based Hierarchy In DSM-6. Article: https://pubmed.ncbi.nlm.nih.gov/42908074/ Dr. Ruffalo Website: https://www.drruffalo.com/ Dr. Pies Psychiatric Times Profile: https://www.psychiatrictimes.com/auth...

A New Long-Acting Injectable: Olanzapine (Zyprexa) Weltruza 21.10.2026

Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza. References: https://pubmed.ncbi.nlm.nih.gov/41632432/ https://pubmed.ncbi.nlm.nih.gov/42198294/ https://www.tevapharm.com/news-and-media/latest-news/new-long-term-safety-data-from-the-completed-phase-3-solaris-trial-support-the-potential-of-olanzapine-la/

Pharmacogenetic Testing in Psychiatry 07.10.2026

Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.

GLP-1 Agonists (Ozempic, Wegovy) in Psychiatry 16.09.2026

Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry. Sources: https://pubmed.ncbi.nlm.nih.gov/42247271/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/ https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205 https://pubmed.ncbi.nlm.nih.gov/42070571 https://pubmed.ncbi.nlm.nih.gov/41806782/

Landmark Studies: The STAR*D Trial 02.09.2026

We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial. References: https://pubmed.ncbi.nlm.nih.gov/12778843/ https://pubmed.ncbi.nlm.nih.gov/19880458/ https://jamanetwork.com/journals/jamapsychiatry/fullarticle/482026 https://pubmed.ncbi.nlm.nih.gov/15061154/ https://pubmed.nc...

Dogs in Mental Health with Dr. Nancy Gee: A Biopsychosocial Approach 19.08.2026

We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject. Dr. Nancy Gee Profile: https://medschool.vcu.edu/about/portfolio/details/geen2/ References: Dogs Supporting Human Health and Well-Being: A Biopsychosoci...

Centanafadine (Simtriyo): A New Medication for ADHD 05.08.2026

Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD. References   https://pmc.ncbi.nlm.nih.gov/articles/PMC12314114/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12379780/ https://pubmed.ncbi.nlm.nih.gov/31776871/ https://pubmed.ncbi.nlm.nih.gov/40619095/ https://pubmed.ncbi.nlm.nih.gov/28731336/ https://p...

Landmark Studies: The CATIE Trial 22.07.2026

Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2005. References: https://www.nejm.org/doi/full/10.1056/NEJMoa051688 https://pubmed.ncbi.nlm.nih.gov/19594194/ https://pubmed.ncbi.nlm.nih.gov/17924259/ https://pubmed.ncbi.nlm.nih.gov/17286522/ https://www.nejm.org/doi/ful...

The Rising Use of Recreational Kratom 08.07.2026

Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pertinent tidbits to know from a psychiatry standpoint. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC8924421/ https://www.ncbi.nlm.nih.gov/books/NBK585120/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10846393/ https://pmc.n...

Modafinil (Provigil) 03.06.2026

Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry. References: Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at:  https://www.accessdata.fda.gov/drugsatfda docs/label/2015/020717s037s038lbl.pdf Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des...

Naltrexone 20.05.2026

Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: https://www.ncbi.nlm.nih.gov/books/NBK534811/ https://pubmed.ncbi.nlm.nih.gov/24825644/ https://pubmed.ncbi.nlm.nih.gov/26798982/ https://www.nejm.org/doi/full/10.1056/NEJMct0801733 https://pubmed.ncbi.nlm.nih.gov/26798982/

Placebo Effect and Response in Psychiatry 06.05.2026

Welcome back! Today, we will be discussing the placebo effect. References: https://pubmed.ncbi.nlm.nih.gov/16503356/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003660/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556377/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714297/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694178 / https://www.psychiatrypodcast.com/psychiatry-psychotherapy-podcast...

Amantadine (Symmetrel) 08.04.2026

Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo) 21.03.2026

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/

A DSM Conversation with Dr. Allen Frances 25.02.2026

We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter of which he served as chair. https://x.com/AllenFrancesMD https://www.amazon.com/stores/author/B001HO76FU https://www.psychiatrictimes.com/authors/allen-frances-md

Topiramate (Topamax) 28.01.2026

Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry. References : https://pubmed.ncbi.nlm.nih.gov/21438989/ https://pubmed.ncbi.nlm.nih.gov/18774432/ https://pubmed.ncbi.nlm.nih.gov/25899459/ https://pmc.ncbi.nlm.nih.gov/articles/PMC1088011/ https://pmc.ncbi.nlm.nih.gov/articles/PMC2671954/ https://pubmed.ncbi.nlm.nih.gov/38706338/ http...

What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa 14.01.2026

Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psychotherapist in private practice in Tampa, FL, and who also serves as Assistant Professor of Psychiatry at the University of Central Florida College of Medicine as well an Adjunct Assistant Professor of Psychiatry at Tufts Universi...

Lorazepam (Ativan) 31.12.2025

Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. But despite anecdotal efficacy, does the evidence hold up? References: https://www.ncbi.nlm.nih.gov/books/NBK532890/ https://pubmed.ncbi.nlm.nih.gov/36805317/ https://pubmed.ncbi.nlm.nih.gov/6120058/ https://pubmed.ncbi.nlm.nih.gov...

The Vitamin Series: Iron Deficiency in Psychiatry 17.12.2025

Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be looking at the role of iron deficiency in psychiatry and do an overview on some of the recent research that's been published. References: https://www.ncbi.nlm.nih.gov/books/NBK557376/ https://www.sciencedirect.com/science/article...

Nutritional Psychiatry with Dr. Laura Lachance 03.12.2025

Welcome back! Today our topic is Nutritional Psychiatry and we've invited a special guest - Dr. Laura Lachance, who has done extensive research in the field. Along with Dr. Drew Ramsey, she has published a paper looking at an Antidepressant Food Score or AFS and more recently, she was a part of the EASe-GAD trial, a study looking at the impact of omega-3 fatty acids on anxiety. Antidepressant...

Stress, Culture, and Determinism with Dr. Robert Sapolsky 19.11.2025

Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford University. He has had extensive research particularly in the field of neuroendocrinology and chronic stress, which has acted as one of the foundations of modern psychoneuroendocrinology. He is also a research associate at the Institute...

SSRIs Revisited: The 100th Episode 05.11.2025

One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests, fans, and listeners. References: https://pmc.ncbi.nlm.nih.gov/articles/PMC4428540/ https://pubmed.ncbi.nlm.nih.gov/10333979⁠ ⁠https://pmc.ncbi.nlm.nih.gov/articles/PMC3663330/⁠

Alprazolam (Xanax) 29.10.2025

Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications. https://www.ncbi.nlm.nih.gov/books/NBK538165/ https://pmc.ncbi.nlm.nih.gov/articles/PMC6769182/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5846112/ https://pubmed.ncbi.nlm.nih.gov/6141930/ https://pubmed.ncbi.nlm.nih.g...

Climate Change and Mental Health with Dr. Ferdnand Osuagwu 22.10.2025

Join us today for an episode on the impact of climate change on mental health. We'll be exploring concepts like eco-anxiety, advocacy, the impact of nuclear war and practical tips. We're joined by guest Dr. Ferdnand Osuagwu, who was the former Chair of the Caucus on Climate Change and Mental Health of the American Psychiatric Association (APA) and founder of the Ferdnand Foundation International,...

Listen to the PsychRounds: The Psychiatry Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.